CJ-16871

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameCJ-16871
Drug Alias NameCJ-16871
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMAP kinase-activated protein kinase 5 inhibitors
TargetsMAP kinase-activated protein kinase 5
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHK inno.N Corporation
China Registration ClassN/A

Develop Information

Active CompaniesHK inno.N Corporation
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A